Search

Displaying results 6881 - 6890 of 10000 in total
  1. Drug

    R906289

    go.drugbank.com/drugs/DB19126
    Investigational

    R906289 is under investigation in clinical trial NCT05308264 (Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)).

  2. Drug

    Beperminogene perplasmid

    go.drugbank.com/drugs/DB19236
    Investigational

    Beperminogene perplasmid is under investigation in clinical trial NCT02144610 (Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia).

  3. Drug

    Honokiol

    go.drugbank.com/drugs/DB19283
    Investigational

    Honokiol is under investigation in clinical trial NCT00966953 (Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.).

  4. Drug

    Caficrestat

    go.drugbank.com/drugs/DB15121
    Investigational

    AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).

  5. Drug

    Lenzilumab

    go.drugbank.com/drugs/DB15148
    Investigational

    Lenzilumab is under investigation in clinical trial NCT02546284 (Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)).

  6. Drug

    Branebrutinib

    go.drugbank.com/drugs/DB15347
    Investigational

    Branebrutinib is under investigation in clinical trial NCT02705989 (Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects).

  7. Drug

    GMA-161

    go.drugbank.com/drugs/DB15397
    Investigational

    GMA-161 is under investigation in clinical trial NCT00244257 (Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)).

  8. Drug

    Bfpet F-18

    go.drugbank.com/drugs/DB15424
    Investigational

    Bfpet F-18 is under investigation in clinical trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy).

  9. Drug

    Ceralifimod

    go.drugbank.com/drugs/DB16123
    Investigational

    Ceralifimod is under investigation in clinical trial NCT01226745 (Phase 2 Extension Trial in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)).

  10. Drug

    Eluforsen

    go.drugbank.com/drugs/DB16154
    Investigational

    Eluforsen is under investigation in clinical trial NCT02532764 (Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients).